Consumer Defensive Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 05/08/2026 | CALL | $20.00 | 10,000 | +10,000 | |
| 05/08/2026 | PUT | $20.00 | 10,000 | +10,000 | |
| 04/17/2026 | CALL | $20.00 | 8,447 | +4,272 | +102.32% |
| 04/10/2026 | CALL | $22.00 | 4,788 | +2,645 | +123.43% |
| 04/02/2026 | CALL | $22.50 | 7,767 | +2,592 | +50.09% |
| 04/10/2026 | CALL | $20.50 | 2,379 | +2,116 | +804.56% |
| 04/17/2026 | PUT | $21.01 | 14,810 | -300 | -1.99% |
| 06/18/2026 | CALL | $24.00 | 585 | -339 | -36.69% |
| 05/15/2026 | CALL | $30.00 | 6,040 | -650 | -9.72% |
| 04/17/2026 | CALL | $21.00 | 15,313 | -770 | -4.79% |
| 04/02/2026 | CALL | $16.00 | 0 | -10,000 | -100.00% |
| 04/02/2026 | PUT | $16.00 | 0 | -10,000 | -100.00% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.78% | 3.57M | 30.96M |
| Vanguard Small-Cap Index Fund | 1.54% | 3.08M | 26.72M |
| iShares Russell 2000 ETF | 1.33% | 2.66M | 23.08M |
| Vanguard Small-Cap Growth Index Fund | 0.89% | 1.78M | 15.39M |
| Franklin Strategic Series-Franklin Small Cap Growth Fund | 0.84% | 1.68M | 14.61M |
| Vanguard Extended Market Index Fund | 0.79% | 1.59M | 13.76M |
| Fidelity Small Cap Index Fund | 0.50% | 997.91k | 8.65M |
| iShares Russell 2000 Growth ETF | 0.39% | 790.2k | 6.85M |
| TIAA-CREF Funds-Quant Small Cap Equity Fund | 0.36% | 717.3k | 6.22M |
| Fidelity Extended Market Index Fund | 0.31% | 621.62k | 5.39M |
Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan
03/31 02:35 pm
Benzinga
Read moreIndia's Generic Wave Hits Ozempic And Wegovy As Prices Drop Sharply
03/23 09:00 am
Benzinga
Read moreNovo Nordisk Secures FDA Approval For Higher-Dose Wegovy
03/19 01:50 pm
Benzinga
Read moreLucid Tops The Most-Shorted Stock List—Here Are 9 More Short Targets
03/11 03:20 pm
Benzinga
Read moreEurope In Review: Natural Gas Prices Spike As Europe Splits Over US‑Israeli Strikes
03/10 10:47 am
Benzinga
Read moreStock Market Today: Dow, Nasdaq 100, S&P 500 Futures Plunge As Oil Prices Jump, Trump Dismisses 'Short Term' Spike— Hims & Hers In Focus (UPDATED)
03/09 09:17 am
Benzinga
Read moreHims & Hers, Novo Nordisk Weight-Loss Drug Deal Ends Legal Feud, Stock Soars
03/09 07:04 am
Benzinga
Read moreHims & Hers: The Telehealth Growth Story Younger Investors Can't Afford to Ignore
02/26 08:17 am
The Motley Fool
Read moreHims & Hers in Free Fall: Why Analysts See Nearly 150% Upside
02/24 10:35 am
Investing.com
Read moreDeal Dispatch: Starboard Targets TripAdvisor, His & Hers Expands, Mister Car Wash Goes Private
02/20 04:40 pm
Benzinga
Read moreHims & Hers Health $1 Billion Eucalyptus Acquisition Fuels Global Expansion Dreams
02/19 09:50 am
Benzinga
Read moreTop 10 Most Shorted Stocks: CleanSpark, Hims & Hers And More
02/13 04:32 pm
Benzinga
Read moreNovo Nordisk Plans Wegovy Vial Launch To Counter Eli Lilly, Target Broader Obesity Market
02/12 02:02 pm
Benzinga
Read moreStock Market Today, Feb. 9: Hims & Hers Health Drops 16% on Novo Nordisk Lawsuit
02/09 07:34 pm
The Motley Fool
Read moreHims & Hers Collapses After FDA Vows to Restrict Copycat GLP-1 Pill. Is the Stock Toast?
02/09 05:07 pm
The Motley Fool
Read moreNovo Nordisk vs. Eli Lilly: What's the Better Long-Term Investment?
02/09 03:30 pm
The Motley Fool
Read moreHims & Hers Under Fire, Stock Tanks on Federal Crackdown, Patent War
02/09 02:03 pm
Benzinga
Read moreNovo Nordisk Takes Legal Action Against Hims & Hers Over Wegovy Knock Offs
02/09 10:46 am
Benzinga
Read moreWhat's Going On With Novo Nordisk Stock On Friday?
02/06 02:51 pm
Benzinga
Read moreHims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026
02/05 09:51 pm
GlobeNewswire Inc.
Read moreAmazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings.
02/05 09:15 pm
The Motley Fool
Read morePharmaZee GLP-1 Prescription Information Updated as Novo Nordisk Raises Compounding Concerns and Consumer Interest in Telehealth Semaglutide Access Grows in 2026
02/05 08:53 pm
GlobeNewswire Inc.
Read moreHims & Hers Launches Compounded Version Of Wegovy, Novo Nordisk Threatens Legal Action
02/05 01:51 pm
Benzinga
Read moreHUGE News: Hims & Hers Adds Cancer Testing to Labs Offering
02/04 12:25 pm
The Motley Fool
Read moreThese 10 Stocks Could Be Short Squeeze Targets: Lucid, Kohl's, Avis and More
02/02 03:08 pm
Benzinga
Read moreKelley Drye Expands Privacy Practice with Partner Kate Black and Special Counsel Mason Fitch
01/26 02:00 pm
GlobeNewswire Inc.
Read more2 Top Stocks to Double Up On Right Now
01/20 08:05 pm
The Motley Fool
Read moreLooking For A Short Squeeze? 10 Stocks Ready To Rocket
01/16 11:41 am
Benzinga
Read moreStocks to Love in 2026
01/12 12:04 am
The Motley Fool
Read moreTop 10 Most Shorted Stocks: Lucid, MARA, Hims and More
12/29 11:30 am
Benzinga
Read moreHigh Short-Interest Stocks to Buy Before Q1 2026
12/10 11:12 am
Investing.com
Read moreWhy Is Hims & Hers Stock Falling, and Should Investors Buy the Dip?
11/26 06:15 am
The Motley Fool
Read moreNovo Nordisk Just Took a Big Swing, Slashing Its GLP-1 Drug Prices. Will It Pay Off for the Healthcare Giant?
11/23 05:30 am
The Motley Fool
Read moreLooking For A Squeeze? Here Are The Top 10 Most Shorted Stocks
11/13 04:05 pm
Benzinga
Read more2 Strong Healthcare Stock Picks for Growth Investors
11/13 09:15 am
The Motley Fool
Read moreHims & Hers Revenue Continues to Surge. Is It Time to Buy the Stock?
11/09 05:35 am
The Motley Fool
Read moreStock Market Today: Dow Jones, Nasdaq Futures Rise After Stellar October Gains— Micron Technology, Palantir, Hims & Hers In Focus (UPDATED)
11/03 09:22 am
Benzinga
Read moreShould Investors Buy UnitedHealth Stock Instead of Hims & Hers Stock?
10/14 07:28 am
The Motley Fool
Read moreWhy Hims & Hers Stock Slipped Today
10/03 06:27 pm
The Motley Fool
Read moreThe Secret to Finding the Next Amazon Is Hiding in Plain Sight
10/01 03:15 am
The Motley Fool
Read more3 Healthcare Stocks Using AI to Drive Growth
09/30 05:04 pm
Investing.com
Read moreHims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy
09/23 10:36 am
Investing.com
Read moreWhy Novo Nordisk Stock Popped Today
09/17 11:02 am
The Motley Fool
Read moreHims & Hers Scrutinized For Marketing Its Product As Similar To Ozempic, Wegovy
09/16 01:26 pm
Benzinga
Read moreHuge News for Hims & Hers Stock
09/16 11:28 am
The Motley Fool
Read moreHims & Hers Bets On Hormonal Health To Revive Investor Confidence
09/10 11:13 am
Benzinga
Read more4 Top Stocks to Buy in September
09/04 06:24 am
The Motley Fool
Read more